Skip to main content
Erschienen in: Pediatric Nephrology 5/2012

01.05.2012 | Review

Novel insights into the physiology of renalase and its role in hypertension and heart disease

verfasst von: Gary Desir

Erschienen in: Pediatric Nephrology | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Renalase is an amine oxidase expressed in kidney, heart, liver, and brain that metabolizes catecholamines. Tissue and plasma levels are decreased in models of hypertension and chronic kidney disease. Its expression is modulated by salt intake, and urinary renalase may regulate catecholamines levels and effect renal sodium and phosphate transport. The renalase knockout mouse is hypertensive in the absence of significant changes in renal function. Sympathetic tone is increased as evidenced by elevated plasma and urine catecholamines. Studies in humans with resistant hypertension indicate that plasma renalase levels are inversely associated with systolic blood pressure. Additionally, a functional mutation in renalase (Glu37Asp), known to be associated with essential hypertension, also predicts more severe cardiac hypertrophy and dysfunction. Lastly, a single dose of recombinant renalase administered subcutaneously to rats with chronic kidney disease or to Spontaneously Hypertensive Stroke Prone rats significantly decreases blood pressure for more than 24 h. Available data suggest that renalase deficiency is associated with increased sympathetic tone and resistant hypertension, and recombinant renalase is a potent antihypertensive agent that may provide a valuable option for treating hypertension in chronic kidney disease.
Literatur
1.
Zurück zum Zitat Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J (2004) Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 65:1009–1016PubMedCrossRef Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J (2004) Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 65:1009–1016PubMedCrossRef
2.
Zurück zum Zitat Koomans HA, Blankestijn PJ, Joles JA (2004) Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol 15:524–537PubMedCrossRef Koomans HA, Blankestijn PJ, Joles JA (2004) Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol 15:524–537PubMedCrossRef
3.
Zurück zum Zitat Hostetter TH (2004) Chronic kidney disease predicts cardiovascular disease. N Eng J Med 351:1344–1346CrossRef Hostetter TH (2004) Chronic kidney disease predicts cardiovascular disease. N Eng J Med 351:1344–1346CrossRef
4.
Zurück zum Zitat Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Eng J Med 351:1296–1305CrossRef Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Eng J Med 351:1296–1305CrossRef
5.
Zurück zum Zitat Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Eng J Med 351:1285–1295CrossRef Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Eng J Med 351:1285–1295CrossRef
6.
Zurück zum Zitat Go AS, Lo JC (2006) Epidemiology of non-dialysis-requiring chronic kidney disease and cardiovascular disease. Curr Opin Nephrol Hypertens 15:296–302PubMedCrossRef Go AS, Lo JC (2006) Epidemiology of non-dialysis-requiring chronic kidney disease and cardiovascular disease. Curr Opin Nephrol Hypertens 15:296–302PubMedCrossRef
7.
Zurück zum Zitat Schlaich MP, Socratous F, Hennebry S, Eikelis N, Lambert EA, Straznicky N, Esler MD, Lambert GW (2009) Sympathetic activation in chronic renal failure. J Am Soc Nephrol 20:933–939PubMedCrossRef Schlaich MP, Socratous F, Hennebry S, Eikelis N, Lambert EA, Straznicky N, Esler MD, Lambert GW (2009) Sympathetic activation in chronic renal failure. J Am Soc Nephrol 20:933–939PubMedCrossRef
8.
Zurück zum Zitat Xu J, Li G, Wang P, Velazquez H, Yao X, Li Y, Wu Y, Peixoto A, Crowley S, Desir GV (2005) Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest 115:1275–1280PubMed Xu J, Li G, Wang P, Velazquez H, Yao X, Li Y, Wu Y, Peixoto A, Crowley S, Desir GV (2005) Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest 115:1275–1280PubMed
9.
Zurück zum Zitat Desir GV (2009) Regulation of blood pressure and cardiovascular function by renalase. Kidney Int 76:366–370PubMedCrossRef Desir GV (2009) Regulation of blood pressure and cardiovascular function by renalase. Kidney Int 76:366–370PubMedCrossRef
10.
Zurück zum Zitat Hennebry SC, Eikelis N, Socratous F, Desir G, Lambert G, Schlaich M (2010) Renalase, a novel soluble FAD-dependent protein, is synthesized in the brain and peripheral nerves. Mol Psychiatry 15:234–236PubMedCrossRef Hennebry SC, Eikelis N, Socratous F, Desir G, Lambert G, Schlaich M (2010) Renalase, a novel soluble FAD-dependent protein, is synthesized in the brain and peripheral nerves. Mol Psychiatry 15:234–236PubMedCrossRef
11.
Zurück zum Zitat Feng W, Nian-song W, Tao X, Yang C, Hai-yan X (2009) The cloning and expression of renalase and the preparation of its monoclonal antibody. J Shanghai Jiaotong Univ Sci 14:376–379CrossRef Feng W, Nian-song W, Tao X, Yang C, Hai-yan X (2009) The cloning and expression of renalase and the preparation of its monoclonal antibody. J Shanghai Jiaotong Univ Sci 14:376–379CrossRef
12.
Zurück zum Zitat Li G, Xu J, Wang P, Velazquez H, Li Y, Wu Y, Desir GV (2008) Catecholamines regulate the activity, secretion, and synthesis of renalase. Circulation 117:1277–1282PubMedCrossRef Li G, Xu J, Wang P, Velazquez H, Li Y, Wu Y, Desir GV (2008) Catecholamines regulate the activity, secretion, and synthesis of renalase. Circulation 117:1277–1282PubMedCrossRef
13.
Zurück zum Zitat Wang J, Qi S, Cheng W, Li L, Wang F, Li YZ, Zhang SP (2008) Identification, expression and tissue distribution of a renalase homologue from mouse. Mol Biol Rep 35:613–620PubMedCrossRef Wang J, Qi S, Cheng W, Li L, Wang F, Li YZ, Zhang SP (2008) Identification, expression and tissue distribution of a renalase homologue from mouse. Mol Biol Rep 35:613–620PubMedCrossRef
14.
Zurück zum Zitat Boomsma F, Tipton KF (2007) Renalase, a catecholamine-metabolising enzyme? J Neural Transm 114:775–776PubMedCrossRef Boomsma F, Tipton KF (2007) Renalase, a catecholamine-metabolising enzyme? J Neural Transm 114:775–776PubMedCrossRef
16.
Zurück zum Zitat Farzaneh-Far RM, Desir GV, Schiller NB, Whooley MA (2010) A functional mutation in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the Heart and Soul Study. PLoS ONE 5(10):e13496PubMedCrossRef Farzaneh-Far RM, Desir GV, Schiller NB, Whooley MA (2010) A functional mutation in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the Heart and Soul Study. PLoS ONE 5(10):e13496PubMedCrossRef
17.
Zurück zum Zitat Desir GV (2008) Renalase deficiency in chronic kidney disease, and its contribution to hypertension and cardiovascular disease. Curr Opin Nephrol Hypertens 17:181–185PubMedCrossRef Desir GV (2008) Renalase deficiency in chronic kidney disease, and its contribution to hypertension and cardiovascular disease. Curr Opin Nephrol Hypertens 17:181–185PubMedCrossRef
18.
Zurück zum Zitat Wang F, N-s W, Xing T, Cao Y, H-y X (2009) The cloning and expression of renalase and the preparation of its monoclonal antibody. J Shanghai Jiaotong Univ Sci 14:376–379CrossRef Wang F, N-s W, Xing T, Cao Y, H-y X (2009) The cloning and expression of renalase and the preparation of its monoclonal antibody. J Shanghai Jiaotong Univ Sci 14:376–379CrossRef
19.
Zurück zum Zitat Schlaich M, Socratous F, Eikelis N, Chopra R, Lambert G, Hennebry S (2010) Renalase plasma levels are associated with systolic blood pressure in patients with resistant hypertension: 9C.01. J Hypertens 28:e437 410.1097/1001.hjh.0000379519.0000382971.0000379502 Schlaich M, Socratous F, Eikelis N, Chopra R, Lambert G, Hennebry S (2010) Renalase plasma levels are associated with systolic blood pressure in patients with resistant hypertension: 9C.01. J Hypertens 28:e437 410.1097/1001.hjh.0000379519.0000382971.0000379502
21.
Zurück zum Zitat Pestana M, Sampaio-Maia B, Moreira-Rodrigues M, Fernandes-Cerqueira C, Quelhas-Santos J (2009) Expression of renalase in a 3/4 nephrectomy rat model. NDT Plus 2:ii55- Pestana M, Sampaio-Maia B, Moreira-Rodrigues M, Fernandes-Cerqueira C, Quelhas-Santos J (2009) Expression of renalase in a 3/4 nephrectomy rat model. NDT Plus 2:ii55-
22.
Zurück zum Zitat Ghosh SS, Gehr TWB, Sica DA, Masilamani S, Fakhry I, Wang R, McGuire E, Ghosh S (2006) Renalase regulates blood pressure in salt sensitive Dahl rats. J Am Soc Nephrol 17:208A Ghosh SS, Gehr TWB, Sica DA, Masilamani S, Fakhry I, Wang R, McGuire E, Ghosh S (2006) Renalase regulates blood pressure in salt sensitive Dahl rats. J Am Soc Nephrol 17:208A
23.
Zurück zum Zitat Wu Y, Velazquez H, Xu J, Wang P, Li G, Liu D, Sampaio-Maia B, Quelhas-Santos J, Russell K, Russell R, Flavell R, Pestana M, Giordano G, Desir G (2010) Renalase deficiency aggravates ischemic myocardial damage. Kidney Int. doi:10.1038/ki.2010.488 Wu Y, Velazquez H, Xu J, Wang P, Li G, Liu D, Sampaio-Maia B, Quelhas-Santos J, Russell K, Russell R, Flavell R, Pestana M, Giordano G, Desir G (2010) Renalase deficiency aggravates ischemic myocardial damage. Kidney Int. doi:10.​1038/​ki.​2010.​488
25.
Zurück zum Zitat Desir G, Giordano F, Liu D, Wu Y (2009) Renalase deficiency aggravates cardiac ischemia and myocardial infarction. NDT Plus 2:ii55 Desir G, Giordano F, Liu D, Wu Y (2009) Renalase deficiency aggravates cardiac ischemia and myocardial infarction. NDT Plus 2:ii55
26.
Zurück zum Zitat Carey RM (2001) Theodore cooper lecture: renal dopamine system: paracrine regulator of sodium homeostasis and blood pressure. Hypertension 38:297–302PubMedCrossRef Carey RM (2001) Theodore cooper lecture: renal dopamine system: paracrine regulator of sodium homeostasis and blood pressure. Hypertension 38:297–302PubMedCrossRef
28.
Zurück zum Zitat Pestana M, Jardim H, Correia F, Vieira-Coelho MA, Soares-da-Silva P (2001) Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension. Nephrol Dial Transplant 16(Suppl 1):53–59PubMedCrossRef Pestana M, Jardim H, Correia F, Vieira-Coelho MA, Soares-da-Silva P (2001) Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension. Nephrol Dial Transplant 16(Suppl 1):53–59PubMedCrossRef
29.
Zurück zum Zitat Ferreira A, Bettencourt P, Pimenta J, Frioes F, Pestana M, Soares-da-Silva P, Cerqueira-Gomes M (2002) The renal dopaminergic system, neurohumoral activation, and sodium handling in heart failure. Am Heart J 143:391–397PubMedCrossRef Ferreira A, Bettencourt P, Pimenta J, Frioes F, Pestana M, Soares-da-Silva P, Cerqueira-Gomes M (2002) The renal dopaminergic system, neurohumoral activation, and sodium handling in heart failure. Am Heart J 143:391–397PubMedCrossRef
31.
Zurück zum Zitat Jose PA, Eisner GM, Felder RA (2003) Dopamine and the kidney: a role in hypertension? Curr Opin Nephrol Hypertens 12:189–194PubMedCrossRef Jose PA, Eisner GM, Felder RA (2003) Dopamine and the kidney: a role in hypertension? Curr Opin Nephrol Hypertens 12:189–194PubMedCrossRef
32.
Zurück zum Zitat Wilk S, Mizoguchi H, Orlowski M (1978) gamma-Glutamyl dopa: a kidney-specific dopamine precursor. J Pharmacol Exp Ther 206:227–232PubMed Wilk S, Mizoguchi H, Orlowski M (1978) gamma-Glutamyl dopa: a kidney-specific dopamine precursor. J Pharmacol Exp Ther 206:227–232PubMed
33.
Zurück zum Zitat Wang ZQ, Way D, Shimizu K, Fong F, Trigg L, McGrath BP (1993) Beneficial acute effects of selective modulation of renal dopamine system by gamma-L-glutamyl-L-dopa in rabbits with congestive heart failure. J Cardiovas Pharmacol 21:1004–1011CrossRef Wang ZQ, Way D, Shimizu K, Fong F, Trigg L, McGrath BP (1993) Beneficial acute effects of selective modulation of renal dopamine system by gamma-L-glutamyl-L-dopa in rabbits with congestive heart failure. J Cardiovas Pharmacol 21:1004–1011CrossRef
34.
Zurück zum Zitat Barthelmebs M, Caillette A, Ehrhardt JD, Velly J, Imbs JL (1990) Metabolism and vascular effects of gamma-L-glutamyl-L-dopa on the isolated rat kidney. Kidney Int 37:1414–1422PubMedCrossRef Barthelmebs M, Caillette A, Ehrhardt JD, Velly J, Imbs JL (1990) Metabolism and vascular effects of gamma-L-glutamyl-L-dopa on the isolated rat kidney. Kidney Int 37:1414–1422PubMedCrossRef
35.
Zurück zum Zitat Cummings J, Matheson LM, Maurice L, Smyth JF (1990) Pharmacokinetics, bioavailability, metabolism, tissue distribution and urinary excretion of gamma-L-glutamyl-L-dopa in the rat. J Pharm Pharmacol 42:242–246PubMedCrossRef Cummings J, Matheson LM, Maurice L, Smyth JF (1990) Pharmacokinetics, bioavailability, metabolism, tissue distribution and urinary excretion of gamma-L-glutamyl-L-dopa in the rat. J Pharm Pharmacol 42:242–246PubMedCrossRef
36.
Zurück zum Zitat Worth DP, Harvey JN, Brown J, Lee MR (1985) gamma-L-Glutamyl-L-dopa is a dopamine pro-drug, relatively specific for the kidney in normal subjects. Clin Sci Lond 69:207–214PubMed Worth DP, Harvey JN, Brown J, Lee MR (1985) gamma-L-Glutamyl-L-dopa is a dopamine pro-drug, relatively specific for the kidney in normal subjects. Clin Sci Lond 69:207–214PubMed
37.
Zurück zum Zitat MacDonald TM, Jeffrey RF, Lee MR (1989) The renal and haemodynamic effects of a 10 h infusion of glutamyl-L-dopa in normal man. Br J Clin Pharmacol 27:811–822PubMed MacDonald TM, Jeffrey RF, Lee MR (1989) The renal and haemodynamic effects of a 10 h infusion of glutamyl-L-dopa in normal man. Br J Clin Pharmacol 27:811–822PubMed
38.
Zurück zum Zitat Seri I, Kone BC, Gullans SR, Aperia A, Brenner BM, Ballermann BJ (1990) Influence of Na+ intake on dopamine-induced inhibition of renal cortical Na(+)-K(+)-ATPase. Am J Physiol 258:F52–F60PubMed Seri I, Kone BC, Gullans SR, Aperia A, Brenner BM, Ballermann BJ (1990) Influence of Na+ intake on dopamine-induced inhibition of renal cortical Na(+)-K(+)-ATPase. Am J Physiol 258:F52–F60PubMed
39.
Zurück zum Zitat Oates NS, Ball SG, Perkins CM, Lee MR (1979) Plasma and urine dopamine in man given sodium chloride in the diet. Clin Sci Lond 56:261–264PubMed Oates NS, Ball SG, Perkins CM, Lee MR (1979) Plasma and urine dopamine in man given sodium chloride in the diet. Clin Sci Lond 56:261–264PubMed
40.
Zurück zum Zitat Soares-da-Silva P (1993) Enhanced protein kinase C mediated inhibition of renal dopamine synthesis during high sodium intake. Biochem Pharmacol 45:1791–1800PubMedCrossRef Soares-da-Silva P (1993) Enhanced protein kinase C mediated inhibition of renal dopamine synthesis during high sodium intake. Biochem Pharmacol 45:1791–1800PubMedCrossRef
41.
Zurück zum Zitat Chan YL (1976) Cellular mechanisms of renal tubular transport of I-dopa and its derivatives in the rat: microperfusion studies. J Pharmacol Exp Ther 199:17–24PubMed Chan YL (1976) Cellular mechanisms of renal tubular transport of I-dopa and its derivatives in the rat: microperfusion studies. J Pharmacol Exp Ther 199:17–24PubMed
42.
Zurück zum Zitat Sampaio-Maia B, Serrao P, Guimaraes JT, Vieira-Coelho MA, Pestana M (2005) Renal dopaminergic system activity in the rat remnant kidney. Nephron Exp Nephrol 99:e46–e55PubMedCrossRef Sampaio-Maia B, Serrao P, Guimaraes JT, Vieira-Coelho MA, Pestana M (2005) Renal dopaminergic system activity in the rat remnant kidney. Nephron Exp Nephrol 99:e46–e55PubMedCrossRef
43.
Zurück zum Zitat Sampaio-Maia B, Moreira-Rodrigues M, Pestana M (2006) Role of chronic inhibition of dopamine-metabolizing enzymes in the regulation of renal sodium and phosphate excretion in the rat remnant kidney. Nephron Physiol 103:p14–p24PubMedCrossRef Sampaio-Maia B, Moreira-Rodrigues M, Pestana M (2006) Role of chronic inhibition of dopamine-metabolizing enzymes in the regulation of renal sodium and phosphate excretion in the rat remnant kidney. Nephron Physiol 103:p14–p24PubMedCrossRef
44.
Zurück zum Zitat Desir G, Tang L, Wang P, Li G, Velazquez H (2010) Antihypertensive effect of recombinant renalase in spontaneously hypertensive stroke prone (SHRSP) Rats. J Am Soc Nephrol 21:748A Desir G, Tang L, Wang P, Li G, Velazquez H (2010) Antihypertensive effect of recombinant renalase in spontaneously hypertensive stroke prone (SHRSP) Rats. J Am Soc Nephrol 21:748A
45.
Zurück zum Zitat Zhao Q, Fan Z, He J, Chen S, Li H, Zhang P, Wang L, Hu D, Huang J, Qiang B, Gu D (2007) Renalase gene is a novel susceptibility gene for essential hypertension: a two-stage association study in northern Han Chinese population. J Mol Med 85:877–885PubMedCrossRef Zhao Q, Fan Z, He J, Chen S, Li H, Zhang P, Wang L, Hu D, Huang J, Qiang B, Gu D (2007) Renalase gene is a novel susceptibility gene for essential hypertension: a two-stage association study in northern Han Chinese population. J Mol Med 85:877–885PubMedCrossRef
46.
Zurück zum Zitat Farzaneh-Far R, Desir GV, Na B, Schiller NB, Whooley MA (2010) A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study. PLoS ONE 5:e13496PubMedCrossRef Farzaneh-Far R, Desir GV, Na B, Schiller NB, Whooley MA (2010) A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study. PLoS ONE 5:e13496PubMedCrossRef
Metadaten
Titel
Novel insights into the physiology of renalase and its role in hypertension and heart disease
verfasst von
Gary Desir
Publikationsdatum
01.05.2012
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 5/2012
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-011-1828-7

Weitere Artikel der Ausgabe 5/2012

Pediatric Nephrology 5/2012 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.